Preclinical Imaging Market Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) - Global Forecast Till 2023

ID: MRFR/HC/5896-HCR | February 2021 | Region: Global | 110 pages

Global preclinical imaging market is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 2.01 billion in 2017 and is projected to grow at a CAGR of 6.3% over the forecast period., The factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches are expected to propel the growth of the market. However, strict regulations in preclinical research and high installation and operational costs associated with preclinical imaging modalities hamper the market growth over the forecast period., Segmentation, The global preclinical imaging market has been segmented into modality, reagent, and region., Based on modality, preclinical imaging market is segmented into optical imaging systems, nuclear imaging systems, micro-MRI, micro-ultrasound, micro-CT, photoacoustic imaging system, and magnetic particle imaging systems. The optical imaging systems segment is expected to account for the largest share segment of the market in 2017., Based on reagent, preclinical imaging market is segmented into preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. The preclinical optical imaging reagents segment is expected to account for the largest share segment of the market in 2017., The preclinical imaging market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The preclinical imaging market in the Americas further segmented into North America and South America, with the North American market divided into the US and Canada., The European preclinical imaging market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe., The preclinical imaging market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The preclinical imaging market in the Middle East & Africa segmented into the Middle East and Africa., Regional Market Summary, Global Preclinical Imaging Market Share (%), by Region, 2017, , Source: Annual Reports and Sec filings, Geographically, the Americas is anticipated to dominate the global preclinical imagin

Market Scenario

The factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches are expected to propel the growth of the market. However, strict regulations in preclinical research and high installation and operational costs associated with preclinical imaging modalities hamper the market growth over the forecast period.

Segmentation

The global preclinical imaging market has been segmented into modality, reagent, and region.

Based on modality, preclinical imaging market is segmented into optical imaging systems, nuclear imaging systems, micro-MRI, micro-ultrasound, micro-CT, photoacoustic imaging system, and magnetic particle imaging systems. The optical imaging systems segment is expected to account for the largest share segment of the market in 2017.

Based on reagent, preclinical imaging market is segmented into preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. The preclinical optical imaging reagents segment is expected to account for the largest share segment of the market in 2017.

The preclinical imaging market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The preclinical imaging market in the Americas further segmented into North America and South America, with the North American market divided into the US and Canada.

The European preclinical imaging market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The preclinical imaging market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The preclinical imaging market in the Middle East & Africa segmented into the Middle East and Africa.

Regional Market Summary

Global Preclinical Imaging Market Share (%), by Region, 2017

Preclinical Imaging Market

Source: Annual Reports and Sec filings

Geographically, the Americas is anticipated to dominate the global preclinical imaging market owing to a well-established player, technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches.

Europe is expected to hold the second largest position in the global preclinical imaging market. The market growth in this region is attributed to increasing funding to support preclinical researches.

The preclinical imaging market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.

The Middle East & Africa has the least share of the preclinical imaging market.

Global Preclinical Imaging Market, by Modality

Optical Imaging Systems
- Bioluminescence/Fluorescence Imaging Systems
- Standalone Fluorescence Imaging Systems
- Optical + X ray/ Optical + CT systems

Nuclear Imaging Systems
- Micro-PET Systems
- Micro-Spect Systems
- Trimodality (Spect/PET/CT) Systems

Micro-MRI

Micro-Ultrasound

Micro-CT

Photoacoustic Imaging System

Magnetic Particle Imaging Systems

Global Preclinical Imaging Market, by Reagent

Preclinical Optical Imaging Reagents
- Bioluminescent Imaging Reagents
- Fluorescent Imaging Reagents

Preclinical Nuclear Imaging Reagents
- Preclinical PET Tracers
- Preclinical Spect Probes

Preclinical MRI Contrast Agents

Preclinical Ultrasound Contrast Agents

Preclinical CT Contrast Agents

Global Preclinical Imaging Market, by Region

Americas
- North America
  - US
  - Canada
- South America

Europe
- Western Europe
  - Germany
  - France
  - Italy
  - Spain
  - UK
- Rest of Western Europe
- Eastern Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

The Middle East & Africa
- Middle East
- Africa

Global Preclinical Imaging Market, by Key Players

Bruker Corporation (US)

MR Solutions (UK)

PerkinElmer (US)

Fujifilm Holdings Corporation (Japan)

Milabs B.V. (The Netherlands)

Mediso Ltd. (Hungary)

Miltenyi Biotec GmbH (Germany)

LI-COR, Inc. (US)

Aspect Imaging (Israel)

Trifoil Imaging (US)

Intended Audience

Preclinical Imaging Manufacturers and vendors

Research organization and CRO

Various research and consulting firms

Frequently Asked Questions (FAQ) :

At what CAGR is the Preclinical Imaging Market projected to grow during the forecast period?

The Preclinical Imaging Market is projected to grow at a 6.3% CAGR between 2018-2023.

Which region is expected to spearhead the Preclinical Imaging Market?

The Americas are expected to spearhead the Preclinical Imaging Market.

Who are the key competitors in the Preclinical Imaging Market?

Key competitors in the Preclinical Imaging Market include Trifoil Imaging (US), Aspect Imaging (Israel), Miltenyi Biotec GmbH (Germany), LI-COR, Inc. (US), Mediso Ltd. (Hungary), Milabs B.V. (The Netherlands), Fujifilm Holdings Corporation (Japan), PerkinElmer Inc. (US), MR Solutions (UK), and Bruker Corporation (US).

What are the different applications of Preclinical Imaging?

It finds extensive applications in cardiac imaging, orthopaedics, anatomical and functional neuroimaging, cancer research, infectious diseases, inflammation, cardiology, and neurology.

What are the strategies adopted by industry players to maintain dominance in the Preclinical Imaging Market?

Strategies adopted by industry players to maintain dominance in the Preclinical Imaging Market include product innovations and launches, partnerships, and mergers.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Reagent Estimation

Chapter 4. Market Dynamics

4.1. Drivers

4.2. Restraints

4.3. Opportunities

4.4. Challenges

Chapter 5. Market Factor Analysis

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Investment Feasibility Analysis

5.4. Pricing Analysis

Chapter 6. Global Preclinical Imaging Market, by Modality

6.1. Introduction

6.2. Optical Imaging Systems